Stockscreener 앱 받기
109.56
0.57%
0.62
시간 외 거래:
109.57
0.010
+0.01%
전일 마감가:
$108.94
열려 있는:
$108.99
하루 거래량:
1.04M
Relative Volume:
0.73
시가총액:
$21.81B
수익:
$7.60B
순이익/손실:
$1.08B
주가수익비율:
20.83
EPS:
5.26
순현금흐름:
$1.26B
1주 성능:
+4.80%
1개월 성능:
+1.39%
6개월 성능:
-1.34%
1년 성능:
-10.37%
1일 변동 폭
$108.47
$109.97
1주일 범위
$103.14
$109.97
52주 변동 폭
$100.67
$133.90
짐머 바이오메트 Stock (ZBH) Company Profile
명칭
Zimmer Biomet Holdings Inc
전화
(574) 267-6131
주소
345 EAST MAIN STREET, WARSAW, IN
ZBH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
109.56 | 21.81B | 7.60B | 1.08B | 1.26B | 5.26 |
|
ABT
Abbott Laboratories
|
113.48 | 196.83B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
383.42 | 146.17B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
98.66 | 145.41B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
88.08 | 112.94B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
69.78 | 41.16B | 6.60B | 4.16B | 490.10M | 6.93 |
짐머 바이오메트 Stock (ZBH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-17 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2024-09-10 | 개시 | Wolfe Research | Peer Perform |
| 2024-07-01 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-05-30 | 개시 | Goldman | Neutral |
| 2024-05-21 | 업그레이드 | Argus | Hold → Buy |
| 2024-01-04 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2023-10-20 | 개시 | ROTH MKM | Neutral |
| 2023-08-28 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2023-05-03 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2023-04-11 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2023-03-31 | 업그레이드 | Jefferies | Underperform → Hold |
| 2023-03-29 | 개시 | UBS | Sell |
| 2023-03-10 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-01-09 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-01-05 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2023-01-03 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-11-23 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | 개시 | Barclays | Underweight |
| 2022-10-12 | 개시 | Jefferies | Underperform |
| 2022-05-27 | 다운그레이드 | Needham | Buy → Hold |
| 2022-04-13 | 다운그레이드 | Truist | Buy → Hold |
| 2022-04-01 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-03-02 | 재개 | BofA Securities | Underperform |
| 2022-03-02 | 다운그레이드 | Loop Capital | Buy → Hold |
| 2022-02-08 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2022-02-08 | 재확인 | Citigroup | Buy |
| 2022-02-08 | 재확인 | Deutsche Bank | Hold |
| 2022-02-08 | 재확인 | JMP Securities | Mkt Outperform |
| 2022-02-08 | 재확인 | JP Morgan | Neutral |
| 2022-02-08 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2022-02-08 | 재확인 | Stifel | Buy |
| 2022-02-08 | 재확인 | Truist | Buy |
| 2022-02-08 | 재확인 | UBS | Neutral |
| 2022-02-08 | 재확인 | Wells Fargo | Underweight |
| 2022-02-02 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-01-19 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2022-01-10 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2022-01-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | 개시 | RBC Capital Mkts | Sector Perform |
| 2021-12-09 | 다운그레이드 | Needham | Strong Buy → Buy |
| 2021-12-07 | 개시 | Loop Capital | Buy |
| 2021-11-23 | 다운그레이드 | Argus | Buy → Hold |
| 2021-09-14 | 재개 | Raymond James | Mkt Perform |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-09 | 업그레이드 | Northland Capital | Market Perform → Outperform |
| 2021-01-04 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2020-12-18 | 재확인 | Needham | Strong Buy |
| 2020-10-20 | 개시 | Northland Capital | Market Perform |
| 2020-09-11 | 개시 | Wolfe Research | Outperform |
| 2020-08-05 | 재확인 | Needham | Strong Buy |
| 2020-04-28 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2020-04-09 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2020-04-07 | 재확인 | Needham | Strong Buy |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Buy |
| 2020-01-08 | 개시 | SunTrust | Buy |
| 2020-01-07 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2020-01-07 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2019-12-04 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2019-10-07 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2019-09-18 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2019-08-12 | 업그레이드 | Argus | Hold → Buy |
| 2019-07-30 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2019-07-29 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2019-06-11 | 업그레이드 | Bernstein | Underperform → Mkt Perform |
| 2019-04-24 | 업그레이드 | Needham | Buy → Strong Buy |
모두보기
짐머 바이오메트 주식(ZBH)의 최신 뉴스
What to Expect From Zimmer Biomet’s Q4 2024 Earnings Report - Nasdaq
Is Zimmer Biomet (ZBH) an Undervalued Defensive Stock for 2025? - Insider Monkey
What To Expect From Zimmer Biomet’s Q4 2024 Earnings Report - Barchart
Gateway Investment Advisers LLC Has $648,000 Stock Holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Border to Coast Pensions Partnership Ltd Boosts Holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet Holdings, Inc. (ZBH): A Bull Case Theory - MSN
Zimmer Biomet Announces Webcast and Conference Call of Fourth Quarter 2024 Financial Results - Kilgore News Herald
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Sold by Bernzott Capital Advisors - MarketBeat
Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Zimmer Biomet to Report Q4 2024 Financial Results on February 6, Announces Earnings Call - StockTitan
Zimmer Biomet Holdings Inc. stock rises Wednesday, still underperforms market - MarketWatch
Meyer Handelman Co. Sells 3,180 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
JP Morgan 2025: Zimmer Biomet bullish on a strong market return in 2025 - Yahoo Finance
Zimmer Biomet Holdings Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Peddock Capital Advisors LLC Makes New Investment in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Acquired by Reinhart Partners LLC. - MarketBeat
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Purchased by ORG Partners LLC - MarketBeat
ST Germain D J Co. Inc. Trims Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
NeuroOne Medical Revenue Surges 520% to Record $6.2M, Boosted by Zimmer Biomet Deal - StockTitan
Autologous Conditioned Plasma Market Poised for 11.6% CAGR Growth through 2034 | Fact.MR Report - GlobeNewswire Inc.
Bunion correction systems Market Key Players AnalysisStryker - openPR
Zimmer Biomet Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Sold by Douglas Lane & Associates LLC - MarketBeat
Zimmer Biomet (NYSE:ZBH) Sets New 12-Month LowHere's Why - MarketBeat
Dental Crowns and Bridges Market Trends and Growth Forecast - GlobeNewswire
Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2023 - GuruFocus.com
Zimmer Biomet Announces Key Updates to Company's Executive Leade - GuruFocus.com
Zimmer Biomet: Back On Offense With Strong Cash Flow Outlook - Seeking Alpha
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Zimmer Biomet Holdings Inc. stock rises Friday, still underperforms market - MarketWatch
Oversold Conditions For Zimmer Biomet Holdings (ZBH) - Nasdaq
Zimmer Biomet price target raised to $113 from $110 at Evercore ISI - Yahoo Finance
ZIMMER BIOMET HOLDINGS, INC. - Marketscreener.com
Zimmer Biomet: The Valuation Discount Is Not Justified - Yahoo Finance
Biomet Hip Lawsuit Filed Over Defective M2A Metal-on-Metal Implant - AboutLawsuits.com
ZBH Stock to Benefit From Global Expansion Despite Macro Issues - Yahoo Finance
Zimmer Biomet Holdings (NYSE:ZBH) Could Be A Buy For Its Upcoming Dividend - Simply Wall St
Principal Financial Group Inc. Trims Stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet Holdings Inc. stock rises Tuesday, still underperforms market - MarketWatch
Zimmer Biomet Holdings (NYSE:ZBH) Is Due To Pay A Dividend Of $0.24 - Simply Wall St
Zimmer Biomet to Present at the 43rd Annual J.P. Morgan Healthcare Conference - Kilgore News Herald
Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2024 - The Eastern Progress Online
Zimmer Biomet to Present at the 43rd Annual J.P. Morgan Healthca - GuruFocus.com
How Is Zimmer Biomet Holdings' Stock Performance Compared to Other Medical Device Stocks? - MSN
Zimmer Biomet to Present at J.P. Morgan Healthcare Conference 2025: Key Insights Coming - StockTitan
Zimmer Biomet receives FDA 510(k) clearance for stemless total shoulder replacement system - Healio
Zimmer Biomet price target raised to $118 from $117 at Truist - Yahoo Finance
Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2024 - The Malaysian Reserve
Total Wrist Replacement Market Top PlayersZimmer Biomet, - openPR
짐머 바이오메트 (ZBH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.25%
0.27%
자본화:
|
볼륨(24시간):